In this interview, NewsMedical talks to Cerba’s Lukasz Wulnikowski about the power of automation and how it has drastically changed the way the company approaches kit building lines.
Korea-based Bridge Biotherapeutics closes Boston office
Bridge Biotherapeutics has closed its Boston-area discovery wing, according to sources familiar with the decision by the South Korean drug developer. The closure came in
June 25, 2024